Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer

Yingqiu Xie, Haiyan Fan, Wenfu Lu, Qing Yang, Ayan Nurkesh, Tleubek Yeleussizov, Aisulu Maipas, Jiang Lu, Limara Manarbek, Zhenbang Chen, Enrico Benassi

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint Dive into the research topics of 'Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences